X3 News https://www.x3news.com/ X3 News RSS bg-bg Sopharma AD https://www.x3news.com/displayNovina.jsp?formid=190146 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Fri, 20 Jun 2025 14:44:03 +03:00 Sopharma AD https://www.x3news.com/displayNovina.jsp?formid=190145 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Fri, 20 Jun 2025 14:40:58 +03:00 Sopharma AD https://www.x3news.com/displayNovina.jsp?formid=190131 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Fri, 20 Jun 2025 13:03:41 +03:00 Wiser Technology AD https://www.x3news.com/displayNovina.jsp?formid=190128 Other unregulated information Fri, 20 Jun 2025 10:55:16 +03:00 Wiser Technology AD https://www.x3news.com/displayNovina.jsp?formid=190127 Minutes from a General shareholders meeting Fri, 20 Jun 2025 10:43:54 +03:00 Sopharma AD https://www.x3news.com/displayNovina.jsp?formid=190126 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Fri, 20 Jun 2025 10:08:37 +03:00 Shelly Group SE https://www.x3news.com/displayNovina.jsp?formid=190120 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Thu, 19 Jun 2025 17:15:22 +03:00 CB First Investment Bank AD https://www.x3news.com/displayNovina.jsp?formid=190098 Minutes from a General shareholders meeting Thu, 19 Jun 2025 15:57:10 +03:00 Sopharma AD https://www.x3news.com/displayNovina.jsp?formid=190096 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Thu, 19 Jun 2025 15:51:01 +03:00 Sopharma AD https://www.x3news.com/displayNovina.jsp?formid=190082 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Thu, 19 Jun 2025 14:05:28 +03:00 Eurohold Bulgaria AD https://www.x3news.com/displayNovina.jsp?formid=190081 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Thu, 19 Jun 2025 13:22:25 +03:00 Sopharma AD https://www.x3news.com/displayNovina.jsp?formid=190080 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Thu, 19 Jun 2025 13:20:00 +03:00 Sopharma AD https://www.x3news.com/displayNovina.jsp?formid=190068 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Thu, 19 Jun 2025 10:18:10 +03:00 Sopharma AD https://www.x3news.com/displayNovina.jsp?formid=190040 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Wed, 18 Jun 2025 15:02:39 +03:00 Herti AD https://www.x3news.com/displayNovina.jsp?formid=190038 Sustainability information Wed, 18 Jun 2025 14:47:23 +03:00 Sopharma AD https://www.x3news.com/displayNovina.jsp?formid=190035 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Wed, 18 Jun 2025 14:17:32 +03:00 Sirma Group Holding AD https://www.x3news.com/displayNovina.jsp?formid=190026 Sustainability information Wed, 18 Jun 2025 11:26:52 +03:00 Bulgarian Energy Holding EAD https://www.x3news.com/displayNovina.jsp?formid=190011 Semi-annual report in pursuance of Art. 100f (1), item 2 in relation to Art. 100f (2) of the POSA about fulfilment of the obligations of an issuer, related to its bond issue Tue, 17 Jun 2025 15:45:01 +03:00 Shelly Group SE https://www.x3news.com/displayNovina.jsp?formid=190002 Other unregulated information Tue, 17 Jun 2025 14:55:36 +03:00 Sopharma AD https://www.x3news.com/displayNovina.jsp?formid=190000 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Tue, 17 Jun 2025 14:48:54 +03:00 Sopharma AD https://www.x3news.com/displayNovina.jsp?formid=189995 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Tue, 17 Jun 2025 13:26:11 +03:00 Sopharma AD https://www.x3news.com/displayNovina.jsp?formid=189988 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Tue, 17 Jun 2025 11:11:58 +03:00 Eurohold Bulgaria AD https://www.x3news.com/displayNovina.jsp?formid=189948 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Mon, 16 Jun 2025 13:52:42 +03:00 Sopharma AD https://www.x3news.com/displayNovina.jsp?formid=189946 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Mon, 16 Jun 2025 13:46:46 +03:00 Sopharma AD https://www.x3news.com/displayNovina.jsp?formid=189945 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Mon, 16 Jun 2025 13:16:53 +03:00 Sopharma AD https://www.x3news.com/displayNovina.jsp?formid=189932 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Mon, 16 Jun 2025 11:22:51 +03:00 Advance Terrafund REIT https://www.x3news.com/displayNovina.jsp?formid=189931 Other unregulated information Mon, 16 Jun 2025 11:15:29 +03:00